Chemistry:Fasiplon
From HandWiki
Short description: Chemical compound
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C13H15N5O2 |
| Molar mass | 273.296 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Fasiplon binds strongly to benzodiazepine sites on the GABAA receptor and has similar anxiolytic effects in animals, but with less sedative or muscle relaxant action.[1] It was developed by a team at Roussel Uclaf in the 1990s[2]
References
- ↑ "2-(oxadiazolyl)- and 2-(thiazolyl)imidazo[1,2-a]pyrimidines as agonists and inverse agonists at benzodiazepine receptors". Journal of Medicinal Chemistry 34 (7): 2060–7. July 1991. doi:10.1021/jm00111a021. PMID 1648620.
- ↑ US Patent 5869481 Anticonvulsive 1-ar(alk)ylimidazolin-2-ones and process for making
| 5-HT1AR agonists | |
|---|---|
| GABAAR PAMs |
|
| Gabapentinoids (α2δ VDCC blockers) | |
| Antidepressants |
|
| Sympatholytics (Antiadrenergics) |
|
| Others | |
| |
0.00 ![]() ![]() ![]() ![]() (0 votes) |
